Skip to main content
European Commission logo print header

Article Category

Content archived on 2023-03-01

Article available in the following languages:


CORDIA 's successful debut ensures permanent place on European biotech

CORDIA 2003, the new European biotech convention and the first of its kind in Europe, closed its doors last Thursday in Vienna after a highly successful first event.

The European biotechnology industry was extremely well represented, with companies, investors, and national organisations from more than 37 countries. The participants praised the quality of the conference sessions, where high profile speakers debated the present and future issues affecting every aspect of biotechnology: R&D, manufacturing, financing, partnering strategies, and regulatory policies. Speaking at the opening Plenary, Ireland's Deputy Prime Minister Mary Harney said that: "Biotechnology will be the industry of the Century." However, she added that Europe and the European Union have a lot of work to do to reach the goals for building competitive economies. Kristin Sandereid, CEO of Predimed, Norway, who attended the conference declared: "This has been an excellent event for networking and business development. We have met people here who we have been trying to see for months." "The quality of visitors at CORDIA was excellent!" added Dr Duncan McGregor, Research Manager at Isogenica, UK. The organisers have announced that CORDIA 2004 will take place in Cannes, in the prestigious Palais des Festivals, from 30th November to the 2nd December 2004. ,NOTES TO EDITORS: About CORDIA,The first convention of its kind in Europe, CORDIA - EuropaBio Convention 2003 took place from 2-4 December 2003 at the Messe Wien, Vienna, Austria. CORDIA - EuropaBio Convention 2003, was the first Pan-European biotechnology Conference specifically tailored for the sector. Through partnering, networking and exhibitions, it aimed at exploring and influencing the issues impacting on bioscience growth across Europe including technology transfer, product development and commercialisation, regulation, capital and resourcing. The Convention has been an opportunity to showcase science and technology innovations, and provided the European industry with an unprecedented critical mass for learning, networking and doing business. CORDIA - EuropaBio Convention 2003 has provided an environment for small, medium and large life science and biotech companies in the sector, along with investors, regulators, policy-makers, contract service providers and advisors as well as entrepreneurial scientists and clinicians to meet up and explore the potential of their business together. CORDIA 2003 has been organised by three partners; EuropaBio, the European Association for Bioindustries, Technomark the specialist life science consulting and investment group and Reed Exhibitions, the world's largest event organiser. EuropaBio represents about 35 member companies operating worldwide and 22 national biotechnology associations with over 1200 SME members. Industry representatives, financiers, regulators, patients, NGO's, and politicians have all been involved in preparations to ensure relevant, high-level conference topics and seminars. Contacts For all countries except Germany, Austria and Switzerland:,Richard Anderson at the CORDIA Press Office, ,De Facto Communications plc ,E-mail: ,+44 (0) 207 496 3310 For Germany, Austria and Switzerland:,Till C. Jelitto at the CORDIA Press Office, ,PR & D,E-mail: ,+43 1 505 70 44,